Indraprastha Medical Corporation Ltd.
BSE: 532150 | Sector: Health care |
NSE: INDRAMEDCO | ISIN Code: INE681B01017 |
BSE 00:00 | 15 Jan | 57.10 |
0 (0.00%) |
OPEN
58.50 |
HIGH
58.50 |
LOW
56.70 |
NSE 00:00 | 15 Jan | 57.15 |
0 (0.00%) |
OPEN
57.15 |
HIGH
58.00 |
LOW
56.65 |
OPEN | 58.50 |
PREVIOUS CLOSE | 57.10 |
VOLUME | 22121 |
52-Week high | 69.80 |
52-Week low | 27.45 |
P/E | |
Mkt Cap.(Rs cr) | 523 |
Buy Price | 56.50 |
Buy Qty | 316.00 |
Sell Price | 57.30 |
Sell Qty | 100.00 |
Indraprastha Medical Corporation Ltd. (INDRAMEDCO) - News Sector
-
Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec
7.22 am | 15 Jan 2021 | Business Standard
The stock price of Cadila Healthcare has broken out from the consolidation which held for last three weeks
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Testing recovery gains factored in Thyrocare Technologies stock
11.57 pm | 12 Jan 2021 | Business Standard
Margin pressures and valuations would limit major upsides
-
Stocks to watch: GAIL, Tata Motors, Dishman Carbogen, DRL, Karnataka Bank
8.46 am | 12 Jan 2021 | Business Standard
Jaguar Land Rover's retail sales fell 9 per cent YoY to 1,28,469 units in the October-December quarter
-
Stocks to watch: GAIL, Tata Motors, Dishman Carbogen, DRL, Karnataka Bank
8.46 am | 12 Jan 2021 | Business Standard
Jaguar Land Rover's retail sales fell 9 per cent YoY to 1,28,469 units in the October-December quarter
-
Pfizer compiling data to answer DCGI queries on coronavirus vaccine
1.51 am | 12 Jan 2021 | Business Standard
Drug major clarifies it could not present itself before the SEC because of short notice and time zone issues
-
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
1.11 am | 11 Jan 2021 | Business Standard
Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
-
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
1.11 am | 11 Jan 2021 | Business Standard
Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
-
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
1.11 am | 11 Jan 2021 | Business Standard
Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
-
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
1.11 am | 11 Jan 2021 | Business Standard
Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
-
Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost
1.11 am | 11 Jan 2021 | Business Standard
Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni...
-
Piramal contests US-based Oaktree Capital's offer for bankrupt DHFL
10.19 pm | 8 Jan 2021 | Business Standard
The tier I capital of DHFL has already been completely written off and the existing lenders will be taking a substantial write-down on their loans
-
Strides dips 6% from high on profit booking as Aditya Puri joins as advisor
10.48 am | 8 Jan 2021 | Business Standard
In the past six months, the stock has zoomed 130 per cent, as compared to 33 per cent rally in the S&P BSE Sensex
-
Sun Pharma rises 3%, hits over 2-year high on steady earnings visibility
10.33 am | 8 Jan 2021 | Business Standard
The board of directors of Sun Pharma are scheduled to meet on January 29, 2021 to consider and approve Q3 results
-
Biocon gains 2% after arm gets Rs 555 crore capital injection from ADQ
9.46 am | 8 Jan 2021 | Business Standard
ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, valuing Biocon Biologics at a post money valuation of arou...
-
Stocks to watch: TCS, Biocon, Bharat Rasayan, Vodafone Idea, Tata Power
8.39 am | 8 Jan 2021 | Business Standard
Biocon announced that its subsidiary Biocon Biologics has approved a primary equity investment by Abu Dhabi-based ADQ, one of the region's largest hol...
Quick Links for Indraprastha Medical Corporation:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices